Understanding what a business is worth is an important step for any owner considering a sale. While valuation is often discussed in terms of a multiple of EBITDA, the process is more nuanced. Two companies with the same revenue and profitability can receive very different valuations depending on the quality, sustainability, and risk associated with those earnings.
This article is intended as a foundational overview of the factors that most commonly influence value. Consider it a starting point for owners who are early in thinking about a sale, or who want a refresher before a more formal valuation conversation with an advisor.
For small-to-mid-sized healthcare companies, several factors tend to have the greatest influence on valuation.
Financial Performance and EBITDA
A company's historical and current financial performance provides the foundation for its valuation. Buyers typically focus on adjusted EBITDA, which attempts to measure the ongoing profitability of the business after accounting for legitimate non-recurring or discretionary owner-specific expenses. The absolute size of EBITDA also matters. Larger companies often command higher valuation multiples because they tend to have greater scale, stronger infrastructure, and less dependence on individual employees or customers.
Healthcare Verticals
The specific healthcare vertical in which a company operates can have a significant impact on the EBITDA multiple applied to the business. Certain sectors may command higher multiples due to factors such as growth potential, reimbursement stability, market demand, and overall investor interest.
Growth and Profitability Trends
Buyers are not simply purchasing historical earnings. They are investing in the company's expected future performance. Consistent revenue and EBITDA growth can therefore have a significant positive impact on valuation. Conversely, declining revenue, contracting margins or inconsistent financial performance may result in a lower multiple. Buyers will also evaluate whether recent growth is sustainable and whether there are identifiable opportunities to continue growing after the transaction.
Payer and Revenue Mix
For healthcare companies, the source and quality of revenue can be just as important as the amount of revenue generated. Buyers evaluate the company's mix of Medicare, Medicaid, commercial insurance, private pay, and other reimbursement sources, as well as the stability of reimbursement within each category. Heavy reliance on a single payer or reimbursement program may create additional risk and negatively affect valuation.
Concentration Risk
Revenue concentration is another important consideration. A business that depends heavily on one customer, referral source, facility, payer, or contract may be viewed as riskier than a company with a well-diversified revenue base. Buyers will assess both the percentage of revenue associated with key relationships and the likelihood those relationships will continue following a change in ownership.
Owner and Key-Person Dependence
A company's ability to operate successfully without its current owner is critical to its transferability. If the owner generates a significant portion of revenue, maintains key referral relationships, or manages most day-to-day operations, a buyer may perceive greater transition risk. Companies with established management teams, diversified provider bases, and documented processes are generally more attractive acquisition candidates.
Regulatory and Compliance Considerations
Healthcare businesses operate in highly regulated environments, making compliance an important component of valuation. Buyers may evaluate billing and coding practices, licensing, credentialing, reimbursement audits, regulatory history, and other compliance matters. Significant compliance concerns can affect transaction structure, purchase price, or even a buyer's willingness to proceed with a transaction. A history of litigation or an ongoing lawsuit may create additional risk and cause potential buyers to approach a transaction with greater caution.
Putting It All Together
The factors covered in this piece don't operate independently. A company's payer mix, growth trajectory, and owner dependence all interact to shape how a buyer perceives risk, and ultimately, value. While the considerations outlined here apply broadly across healthcare, their relative weight can vary in areas including vertical, deal size, and buyer type.
For owners who are beginning to think about a future transaction, even one that may still be years away, the earlier an owner understands these dynamics, the more options they have when it's time to sell. VERTESS works with healthcare business owners across numerous verticals to assess these factors in the context of their specific business and prepare for a successful transaction. Contact VERTESS to talk through where your business stands today.
About The Author
Ernest works closely with clients to provide valuation, financial analysis, and consulting support throughout the M&A process. He helps business owners gain clarity around value, prepare for transactions, and make informed decisions from start to finish. Prior to joining VERTESS, McAlister worked as an actuary and later served as Vice President of a construction company, where he managed all aspects of the company’s finances.